KKR
Another one for the deal scrapbook
KKR-backed Global Medical Response (GMR) is reportedly shopping a potential IPO and has already tapped a syndicate of banks to help shepherd the offering. The company is said to be targeting about $1 billion in proceeds, which is not exactly pocket change even in private-equity land.
Why investors should care
If this deal gets off the ground, it gives KKR a fresh path to cash out part of a healthcare-services asset that it built through two big acquisitions: Air Medical Group Holdings in 2015 and American Medical Response in 2017. In other words, this is classic PE math — buy, combine, optimize, then try to hand the thing off to public-market buyers when the timing looks right.
The catch: the market is being picky
The IPO window has been open in theory, but not exactly throwing confetti. New listings are facing a cautious market, so GMR’s success could become a useful little stress test for investor appetite in healthcare services.
Big picture
For KKR, this is a potential liquidity event. For everyone else, it’s a reminder that the IPO market still has all the enthusiasm of a kid being told to wait five more minutes before dessert.